Sign in Subscribe
Cancer

Diverse Antitumour and Antimicrobial Bioactivities of Endophytic Streptomycetes

Strategic Insights

— 1 min read

Scientists at Yunnan University in the People's Republic of China have discovered that endophytic streptomycetes isolated from pharmaceutical plants in the rainforest exhibit remarkable and diverse antitumour and antimicrobial bioactivities. The researchers isolated 41 endophytic actinomycetes from pharmaceutical plants in the rainforest and screened them for antitumour and antimicrobial activities. The study found that many of these isolates showed significant activities against various cancer cells and microorganisms, highlighting their potential as bioactive agents.

Key Takeaways:

  • The researchers isolated 41 endophytic actinomycetes from pharmaceutical plants in the rainforest and screened them for antitumour and antimicrobial activities.
  • Among the isolates, 31.7% were cytotoxic against A549 cells, 29.3% against HL-60 cells, 85.4% against BEL-7404 cells, and 90.2% against P388D1 cells.
  • 65.9% of the isolates were active against Escherichia coli, 24.4% against Staphylococcus aureus, and 12.2% against Candida albicans.
  • High frequencies of positive PCR amplification were obtained for PKS-I (34.1%), PKS-II (63.4%), and NRPS (61.0%) biosynthetic systems.
  • The researchers concluded that these endophytic streptomycetes are precious resources obtained from rainforests and could be a promising source for bioactive agents.
  • The study highlights the potential of endophytic streptomycetes as a source of novel antitumour and antimicrobial agents.

Statistics:

  • 41 endophytic actinomycetes were isolated from pharmaceutical plants in the rainforest.
  • 31.7% of isolates were cytotoxic against A549 cells.
  • 29.3% of isolates were cytotoxic against HL-60 cells.
  • 85.4% of isolates were cytotoxic against BEL-7404 cells.
  • 90.2% of isolates were cytotoxic against P388D1 cells.
  • 65.9% of isolates were active against Escherichia coli.
  • 24.4% of isolates were active against Staphylococcus aureus.
  • 12.2% of isolates were active against Candida albicans.
  • 34.1% of isolates showed positive PCR amplification for PKS-I.
  • 63.4% of isolates showed positive PCR amplification for PKS-II.
  • 61.0% of isolates showed positive PCR amplification for NRPS.

Sources:

  • J. Li, et al. (2008). Antitumour and antimicrobial activities of endophytic streptomycetes from pharmaceutical plants in rainforest. Letters in Applied Microbiology, 47(6), 574-580.
  • Blackwell Publishing, 9600 Garsington Rd., Oxford OX4 2DQ, Oxon, England (Publisher contact information for the journal Letters in Applied Microbiology).

Read more